SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-006138
Filing Date
2015-11-09
Accepted
2015-11-09 11:23:10
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gff10q_110915.htm 10-Q 161123
2 EXHIBIT 31.1 exh_311.htm EX-31.1 7396
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7136
4 EXHIBIT 32 exh_32.htm EX-32 3410
  Complete submission text file 0001171843-15-006138.txt   1179227

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE caps-20150930.xml EX-101.INS 133824
6 XBRL SCHEMA FILE caps-20150930.xsd EX-101.SCH 20658
7 XBRL CALCULATION FILE caps-20150930_cal.xml EX-101.CAL 19215
8 XBRL DEFINITION FILE caps-20150930_def.xml EX-101.DEF 88504
9 XBRL LABEL FILE caps-20150930_lab.xml EX-101.LAB 121556
10 XBRL PRESENTATION FILE caps-20150930_pre.xml EX-101.PRE 104030
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21214 | Film No.: 151214628
SIC: 2834 Pharmaceutical Preparations